For the Inventor, By the Inventor

Enter assignee name

Berkeley, CA, United States of America

Biotime, Inc.

USPTO Granted Patents = 35

% Expired Patents = 11.4

CIPO Patents = 4

EPO Patents = 1

Trademarks = 7

Forward Citations = 725

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Hal Sternberg (32 out of 40 patents)

Paul E Segall (31 out of 33 patents)

Harold D Waitz (31 out of 34 patents)

4. Judith M Segall (23 out of 23 patents)

5. Bruce Cohen (4 out of 4 patents)

6. Michael D West (3 out of 46 patents)

7. Karen B Chapman (2 out of 33 patents)

8. Dana Larocca (1 out of 5 patents)

9. Paola A Bignone (1 out of 3 patents)

10. Thomas Zarembinski (1 out of 1 patent)

11. Isaac Erickson (1 out of 1 patent)

12. Nathaniel Doty (1 out of 1 patent)

13. Evan Y Snyder (1 out of 11 patents)

14. Stanley T Carmichael (3 patents)

15. Andrew N Clarkson (1 patent)

35 patents: Sort by Forward Citations

1. 10227561 - Methods and compositions for targeting progenitor cell lines (2019-03-12),

2. 10137199 - Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione (2018-11-27),

3. 9732128 - Methods of modifying transcriptional regulatory networks in stem cells (2017-08-15),

4. 8685386 - Methods and compositions for in vitro and in vivo chondrogenesis (2014-04-01),

5. 7943292 - Physiologically acceptable aqueous solutions and methods for their use (2011-05-17),

6. 7503913 - Methods and compositions for use in perfusion applications (2009-03-17),

7. 6991624 - Methods and compositions for use in perfusion applications (2006-01-31),

8. 6680305 - Physiologically acceptable aqueous solutions and methods for their use (2004-01-20),

9. 6627393 - Solutions for use as plasma expanders and substitutes (2003-09-30),

10. 6589223 - Method and compositions for use in perfusion applications (2003-07-08),

11. 6506549 - Plasma expanders and blood substitutes (2003-01-14),

12. 6444418 - Plasma-like solution (2002-09-03),

13. 6410218 - Plasma-like solution (2002-06-25),

14. 6406839 - Methods for using a plasma-like solution (2002-06-18),

15. 6387612 - Method of preparing a terminally heat sterilized plasma-like solution (2002-05-14),

BioTime, Inc. is a biotechnology company that focuses on the development of regenerative medicine and therapeutic products. With a strong emphasis on pluripotent stem cell technology, the company aims to address various degenerative diseases and age-related conditions. BioTime's innovative research and strategic collaborations drive the development of novel treatment options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

35 Patents

#20 in Berkeley, CA

#2,302 in California

#9,730 in US

#19,119 in the World

Berkeley, CA, United States of America

Biotime, Inc.

Forward Citations = 725

13 inventors:

Hal Sternberg (32 out of 40 patents)

Paul E Segall (31 out of 33 patents)

Harold D Waitz (31 out of 34 patents)

4. Judith M Segall (23 out of 23 patents)

5. Bruce Cohen (4 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…